Announcing the SCI Accelerate 2022 Cohort

We are excited to announce the 2022 cohort of Praxis SCI Accelerate, a 12 week in residence accelerator program focused on advancing the commercialization of technology to transform the lives of people with spinal cord injury (SCI). Our cohort, encompassing companies across the key SCI focus areas for Praxis represent a variety of backgrounds and have already demonstrated significant traction…
Read More

A Molecular Mechanism for High Salt Taste in Drosophila

Dietary salt detection and consumption are crucial to maintaining fluid and ionic homeostasis. To optimize salt intake, animals employ salt-dependent activation of multiple taste pathways. Generally, sodium activates attractive taste cells, but attraction is overridden at high salt concentrations by cation non-selective activation of aversive taste cells. In flies, high salt avoidance is driven by both “bitter” taste neurons and…
Read More
Approved drugs for the treatment of osteoporosis can prevent further bone loss but do not stimulate bone formation. Approaches that improve bone density in metabolic diseases are needed. Therapies that take advantage of the ability of mesenchymal stem cells (MSCs) to differentiate into various osteogenic lineages to treat bone disorders are of particular interest. Here we examine the ability of…
Read More
STEMCELL Technologies, Canada’s largest biotechnology company, announced today that it has received ISO 14001:2015 certification of its Environmental Management System at its Canadian operations in Vancouver, BC. STEMCELL’s now-certified Environmental Management System will enable the company to monitor, measure, analyze, and evaluate its environmental performance.
Read More
Clinical trials are essential scientific studies that evaluate the safety, effectiveness, and outcomes of health interventions such as vaccines and treatments used across Canada to protect Canadians from diseases. The Government of Canada is working to reinforce the clinical trials environment so that we can improve health outcomes for Canadians while ensuring Canada is well-positioned to respond to future pandemics…
Read More
Sixty-one UBC Science faculty members have received a total of $13.6 million in Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grants. The funding is part of 137 new projects led by UBC researchers receiving a total of $28 million in funding announced today. “Discovery is the foundation of all advancements. Through this major investment in some of…
Read More
Faculty of medicine researchers were awarded more than $3.9 million in funding from the Natural Sciences and Engineering Research Council of Canada (NSERC) as part of the 2022 Discovery research programs. UBC-led research garnered more than $32 million in total. The Honourable François-Philippe Champagne, Minister of Innovation, Science, and Industry, and the Honourable Mona Fortier, President of the Treasury Board, announced the investment to…
Read More
Congratulations to Andrew Weng for receiving the Leukemia and Lymphoma Society of Canada (LLSC) Blood Cancer Research Jump Start Grant for this research entitled, “Functional modeling of MYC translocation in follicular lymphoma.” The LLSC has put together this award recognizing that the COVID-19 pandemic has affected researchers’ capacity to conduct their regular research and training activities. The LLSC’s Jump Start Grant is…
Read More
More than a dozen people with cancer who had exhausted all treatment options are alive and cancer-free today thanks to a pioneering Canadian clinical trial of a highly personalized kind of immunotherapy. The results, presented at the 2022 Cell Therapy Transplant Canada Conference, could open the door to a new era of made-in-Canada immunotherapies for cancer. Patients in the trial had…
Read More